Phospho-tau217 (p-tau217) antibody and antigen (Recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-h-p-tau217-Ag01	Phospho-tau217 (p-tau217) antigen	$3090.00
GMP-h-p-tau217-Ag02	Phospho-tau217 (p-tau217) antigen (full length)	$28000.00
GMP-h-p-tau217-Ab01	Anti-human p-tau217 mouse monoclonal antibody (mAb)	$1953.00
GMP-h-p-tau217-Ab02	Anti-human p-tau217 mouse monoclonal antibody (mAb)	$1953.00
GMP-h-p-tau217-Ab03	Anti-human p-tau217 human monoclonal antibody (mAb)	$1953.00
GMP-h-p-tau217-Ab04	Anti-human p-tau217 human monoclonal antibody (mAb)	$1953.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Pruducts	GMP-h-p-tau217-Ag01
Product Name	Phospho-tau217 (p-tau217) antigen
Target/Biomarker	Phospho-tau217 (p-tau217)
Alias of Target/Biomarker	DDPAC, FTDP-17L, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, tau-40, MAPT
Expression platform	synthesized
Isotypes	NA
Bioactivity validation	Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation
Products description	Recombinant Human Phospho-tau217 (p-tau217) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (HPLC)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts	GMP-h-p-tau217-Ag02
Product Name	Phospho-tau217 (p-tau217) antigen (full length)
Target/Biomarker	Phospho-tau217 (p-tau217)
Alias of Target/Biomarker	DDPAC, FTDP-17L, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, tau-40, MAPT
Expression platform	mammalian
Isotypes	Recombinant Antigen
Bioactivity validation	Phospho-tau217 (p-tau217) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation
Products description	Recombinant Human Phospho-tau217 (p-tau217) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (HPLC)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts	GMP-h-p-tau217-Ab01,GMP-h-p-tau217-Ab02
Product Name	Anti-human p-tau217 mouse monoclonal antibody (mAb)
Target/Biomarker	Phospho-tau217 (p-tau217)
Alias of Target/Biomarker	DDPAC, FTDP-17L, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, tau-40, MAPT
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Human Phospho-tau217 (p-tau217) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau217 (p-tau217) antibodies in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human p-tau217 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau217 (p-tau217) antibodies.
Reconized/Reactive Species	Human
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts	GMP-h-p-tau217-Ab03,GMP-h-p-tau217-Ab04
Product Name	Anti-human p-tau217 human monoclonal antibody (mAb)
Target/Biomarker	Phospho-tau217 (p-tau217)
Alias of Target/Biomarker	DDPAC, FTDP-17L, MSTD, MTBT1, MTBT2, PPND, PPP1R103, TAU, tau-40, MAPT
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Human Phospho-tau217 (p-tau217) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Phospho-tau217 (p-tau217) antibodies in p-tau217 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human p-tau217 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species	Human
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation	Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

• Figure A: GeneMedi's GMP-h-p-tau181-Ab01 (Anti-human p-tau181 antibody) is validated to detect the GMP-h-p-tau181-Ag01 (p-tau181 antigen) in ELISA, EC50 = 25.26ng/ml.

• Figure B: GeneMedi's GMP-h-p-tau217-Ab01 (Anti-human p-tau217 antibody) is validated to detect the GMP-h-p-tau217-Ag01 (p-tau217 antigen) in ELISA, EC50 = 25.85ng/ml.

• Figure C: GeneMedi's GMP-h-p-tau231-Ab01 (Anti-human p-tau231 antibody) is validated to detect the GMP-h-p-tau231-Ag01 (p-tau231 antigen) in ELISA. EC50 = 64.34ng/ml.

Click to get more Data / Case study about the product.

Associated products

Target/Biomarker information

Alzheimer Disease(AD)  Recent publications and meeting presentations bolster the evidence that upticks in p-tau181, p-tau217, and p-tau231 occur soon after Aβ begins to accumulate in the brain. That’s years before neurofibrillary tangles can be detected by PET, and decades before symptoms. Researchers predict these markers, which also distinguish AD from other forms of dementia, will lead to more robust tests than those based on Aβ, because of their larger dynamic range—phosphorylated fragments of tau climb by as much as 10-fold in the blood as AD progresses, whereas the Aβ42/40 ratio falls by about 15 percent at most.

About GDU